| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Institute of Animal Science, Agricultural Research Organization, Volcani Center, PO Box 6, Bet Dagan 50250, Israel
1 Department of Chemistry, University of Arizona, Tucson, Arizona 85721, USA
(Requests for offprints should be addressed to M Friedman-Einat; Email: einat{at}agri.huji.ac.il)
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
-MSH and ACTH, also revealed a general similarity between the strains. Under feeding conditions ad libitum, POMC mRNA levels were highly similar in chicks of both strains and this level was significantly reduced upon feed restriction. However, POMC mRNA down-regulation upon feed restriction was more pronounced in layers than in broilers. These results suggest: (i) a role for MC3/4R agonists in the control of appetite; (ii) that the physiological differences between broilers and layers are not related to unresponsiveness of broiler chickens to the satiety signal of MC3/4R ligands. Therefore, these findings suggest that artificial activation of this circuit in broiler chicks could help to accommodate with their agricultural shortcomings of overeating, fattening, and impaired reproduction. |
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
-melanocyte-stimulating hormone (-MSH), is the major activator of MCRs. It is produced from the precursor pro-opiomelanocortin (POMC) protein primarily in the pituitary gland but also at additional sites, including the neurons of the arcuate nucleus of the hypothalamus. The POMC glycoprotein is cleaved by two kinds of endoproteases, the prohormone convertase 1 (PC1, also called PC3), which generates adrenocorticotropic hormone (ACTH) from POMC and the prohormone convertase 2 (PC2), which cleaves ACTH and other parts of POMC to produce -, ß-, and 
-MSHs. Among the MCRs, MC3R and MC4R are most closely related to the control of energy balance and knockout of these receptors induces overeating and obesity in mice (Huszar et al. 1997, Takeuchi & Takahashi 1999, Chen et al. 2000, Williams et al. 2000, Matsumura et al. 2003). Agonists of MC3/4Rs are highly anorexic and antagonists generate orexigenic effects (Kask & Schioth 2000, Schioth et al. 2003). In humans, mutations in MC4R are found in about 4% of the morbidly obese (Vaisse et al. 2000, Farooqi & O’Rahilly 2005). Importantly, in rodents, the melanocortin system has been shown to influence not only food intake but also the reproductive axis (Hohmann et al. 2000, Small et al. 2002, Schioth et al. 2003).
The two most important commercial strains of chickens provide an excellent model system for studying the melanocortin circuit in avians. About 70 years of extensive selective breeding of chickens for high meat yield (broilers) and efficient egg production (layers) have resulted in two dramatically different strains of obese and lean phenotypes respectively. In comparison with layers, broilers are characterized by a much higher food intake and growth rate (Hocking et al. 1997), faster embryo growth rate (Ohta et al. 2004, Sato et al. 2006) and have higher brain levels of dopamine and dihydroxyphenylacetic acid (Saito et al. 2004). In agreement with these results, broilers were also shown to have lower basal metabolic rate (Kuenzel & Kuenzel 1977), physical activity (Saito et al. 2004), and protein degradation rate (Saunderson & Leslie 1988). Broilers and layers were found to differ in their patterns of eating behavior (Bokkers & Koene 2003) and in their response to several orexigenic and anorexic peptides applied by i.c.v. injection at neonatal age. These peptides include glucagon-like peptide-1 (GLP-1) (Tachibana et al. 2006), GLP-1 antagonist exendin (5–39), cocaine- and amphetamine-regulated transcript (Tachibana et al. 2001) and BAGA receptor antagonists (Takagi et al. 2003). Despite these characterizations performed by i.c.v. injections to neonatal chicks, possible interaction between these circuits and their possible contribution to the observed phenotypes of broiler and layer chickens are not yet understood.
The obese phenotype characteristic of broiler strains, fully manifested after sexual maturation, has a major negative impact on the industry due to increased prevalence of mortality and poor reproductive results, manifested as low egg yield and fertility (Mench 2002, Hocking & Robertson 2005, Tolkamp et al. 2005). Therefore, a study of the molecular control mechanisms of energy balance using broiler and layer chickens as a model, is of high importance for agricultural research as well. Chicken homologs to the mammalian MCR and POMC genes have been cloned (Takeuchi et al. 1996, 1998, 1999, Gerets et al. 2000), and found to share significant sequence similarity with their mammalian counterparts. Among the POMC gene products, the putative chicken -MSH, composed of 13 amino acids, is identical to its human counterpart. The other peptides derived from the POMC pre-protein exhibit high sequence similarity as well (Takeuchi et al. 1999). There is also a similarity between the expression profiles of chicken POMC and MCR genes and those of their mammalian homologs, although in chicken there is more pronounced expression in the peripheral tissues (Ottaviani et al. 1997, Takeuchi & Takahashi 1998, Takeuchi et al. 1999, Gerets et al. 2000, Ling et al. 2004). Intracerebroventricular injection of MC3/4R agonists in neonatal chicks or ringdoves has been shown to significantly inhibit food intake (Kawakami et al. 2000, Tachibana et al. 2001, Strader et al. 2003), as well as neuropeptide Y-induced feeding when neuropeptide Y is given simultaneously (Kawakami et al. 2000). However, this is the first report describing the effect of peripherally administered MC3/4R agonist on chickens, a comparison between the two commercial chicken strains representing obese and lean phenotypes, and a comparative analysis of POMC gene expression in the hypothalamus.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
MT-II, Ac-Nle-c[Asp5,DPhe7,Lys10]-alpha-MSH(4–10)-NH2, a cyclic heptapeptide analog of -MSH, has been discovered in V Hruby’s laboratory to be a highly potent MCR agonist (Al–Obeidi et al. 1989a, 1989b, Haskell-Luevano et al. 1994, Schioth et al. 1997, Yang et al. 1997). MT-II was prepared using solid-phase chemistry as described in the above-cited papers.
Animals
Day-old female white Leghorn (Lohman) chicks, representing layer chickens, and Cobb chicks, representing broiler chickens, were purchased from local husbandries (Hasolelim, Kibutz Hasolelim, Israel, and Brown, Hod Hasharon, Israel, respectively). Both chick types were raised in battery brooders. One week before the experiments they were moved into cages with two chicks per cage, and one day before the experiment they were moved to individual cages. Commercial diets (layer diet for layers and broiler diet for broilers) and water were supplied ad libitum, unless otherwise noted. Photo schedule was of a ratio of 14 h light:10 h darkness, but following MT-II injections light was kept for 24 h per day. Chicks were cared for under the guidelines of the Animal Experimentation Committee, ARO, the Volcani Center.
Feed restriction
At 15 days of age, chicks of both strains were given 70% of their food consumption fed ad libitum. After 4 days, the feed restricted chicks from each strain were divided into two groups according to similar body weights (BWs) and minimal variance of BW within groups (n=6). For the analysis of POMC mRNA, 3-week-old broiler and layer chicks were divided into two groups as described above (n=4). Feed restriction was performed similarly to that described above but allowing only 50% of their food consumption fed ad libitum. Feed restriction was for 7 days.
Injection of MT-II
Intravenous injection into the wing vein was performed with either 0.2 ml PBS (control group) or 0.2 ml PBS containing 1 mg/kg BW MT-II (treated group). After injection, chicks were allowed to feed ad libitum. Food consumption, water consumption and BW were measured every hour for the first 8 h and every 24 h thereafter.
mRNA analysis
Total RNA was isolated from the hypothalamus as described previously (Horev et al. 2000). Each sample was pooled from four birds. RNA samples (20 µg/lane) were separated on a 1.2% agarose/2.2 M formaldehyde gel and blotted onto a nylon membrane (Nytran N, Schleicher & Schuell, Tamar, Jerusalem, IL) according to standard procedures (Sambrook & Russell 2001). POMC probe was prepared by reverse transcriptase (RT)-PCR using hypothalamic mRNA from layer chicks as template; forward primer: 5'-agcggcccatgctgggagaac-3' and reverse primer: 5'-ctgacccttcttgtaggcgct-3'. The resulting product was verified by sequencing. Labeling with [32]P-deoxycytidine-triphosphate was carried out with the random priming kit from Roche Diagnostics (Dyn Diagnostics, Keysaria, IL, USA) and specific activity was 1 x 108 cpm/mg DNA. Prehybridization and hybridization at 42 ° C, and washing under high-stringency conditions were performed according to Sambrook and Russell (2001). Membranes were then exposed to x-ray film (Kodak) using a TransScreen-HE intensifying screen (Kodak). Band intensity was calculated with the NIH ImageJ program (Bethesda, MD, USA).
Statistical analysis
All data are expressed as means ± S.E.M. Data were analyzed using the Student’s t-test. Statistics was performed using SAS software (Cary, NC, USA), and a two-tailed significance level of P < 0.05.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
The direct effect of the synthetic MT-II agonist of MC3/4Rs on food intake of broiler and layer chicks was studied following i.v. injection of MT-II (1 mg/kg BW) to 19-day-old chicks. Food intake following a single administration of MT-II or vehicle (PBS) into the wing vein is shown in Fig. 1A and B
. Injection was administered 4 days after feed restriction to 70% of food consumption ad libitum. This feed restriction explains the high food consumption observed for the control groups of both strains of chicks injected with vehicle alone. Despite this feed restriction, during the first hour post injection, the MT-II-treated broilers and layers ate about one-third the amount of food eaten by their corresponding control groups (28 and 33% for broiler and layer chicks respectively).
|
) demonstrate that the treated layers had already matched the cumulative food intake of their control counterparts by 5 h post injection, whereas the treated broilers matched their controls some time between 8 and 24 h after injection. A comparison of the satiety effect of the MT-II treatment on broiler and layer chicks is shown in Fig. 2, where the cumulative food intake of each strain is normalized to their daily food intake. The normalized values show a very strong similarity in the responses of the treated broilers and layers during the first 8 h post injection. It is striking that the biggest difference between the strains lies in the response of their control groups to the feed restriction, which occurred prior to injection, while the response to MT-II treatment was highly similar.
|
) is more complicated, since it reflects not only the real increase in BW but also food accumulation in the crop and the effect of drinking, which increases with elevated food intake (Fig. 4). Nevertheless, the general patterns of cumulative BW shown in Fig. 3 are similar to those of the cumulative food intake (Fig. 1C and D). The main difference is the noticeable reduction in the cumulative BW of layers between 8 and 24 h. This reduction reflects the fact that much of the BW gain during the first hour post exposure to feeding ad libitum evolved from the accumulation of undigested food and water in the crop. However, since feed-conversion efficiencies are higher in broilers compared with layers (Marks 1980, Leenstra & Pit 1988, Morris & Njuru 1990, Gilbert et al. 1999, MacLeod et al. 1999) the reduced BW due to ingestion of the stored food is less pronounced in broilers. Moreover, the higher rate of food intake of the broiler chicks further masked the expected reduction in their apparent BW.
|
|
), obtained by dividing the cumulative BW values by the initial BW of each chick (Fig. 3C), shows that using this criterion as well, treated and control layers reached a similar mean relative BW by 6 h post injection, whereas broiler chicks did the same only between 8 and 24 h post injection. This experiment was repeated a few times using younger (one week of age) and older (4 months of age) hens of both genders and similar results were obtained (not shown). Administration of twofold lower amounts of MT-II did not elicit a response in either broiler or layer chicks (not shown).
Expression analysis of POMC mRNA
As both strains of chicks responded similarly to the exogenous -MSH agonist, we compared the expression of the endogenous POMC gene, which codes for -MSH and other melanocortin peptides in the hypothalamus of the two strains. As shown in Fig. 5, similar levels of POMC mRNA were deserved in the hypothalamus of the two strains. This POMC expression level decreased significantly in chicks of both strains after 7 days of feed restriction (FR broilers and layers). The level of POMC expression in the hypothalamus of feed-restricted layer chicks was lower than that in broiler chicks (12 and 40% relative to the level obtained in broilers fed ad libitum) (Fig. 5C).
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Despite their apparently low sensitivity to satiety signals and their extreme levels of food consumption, broiler chicks were no less sensitive than layer chicks to the attenuation of food intake induced by MT-II treatment. Considering the effective time period of the treatment, broilers seemed to be even more sensitive than layers, since it took them longer to match the amounts of food consumption and BWs of their control counterparts. It could be argued, however, that this difference stems from their inherently higher food consumption mediated through additional signaling circuits, rather than from different sensitivity to the MT-II treatment. This higher tendency of food intake imposes a longer period of time for the treated broiler chicks to match up the amount of food intake to that of their control chicks. This effect of MT-II treatment on food intake was confirmed by our study of BW. However, one should take into account that much of the increase in BW in the first few hours post exposure to feeding ad libitum was due to food accumulation in the crop. At longer time periods, when the contribution of food stores to the measurement of cumulative BW is reduced, the measurements of cumulative BW revealed that after 24 and 5 h for broiler and layers respectively, no significant differences in BW could be observed between the treated and control groups of each strain. At the same time periods, cumulative food intake also equalized between each of the treated groups and its respective control. This could serve as an indirect indication that regardless of the MT-II treatment for each strain, a given amount of food intake resulted in a given amount of BW change, meaning that the MT-II treatment had no major effect on energy expenditure. However, since no direct measurement of energy expenditure was made, small transient effects of MT-II treatment on energy expenditure, which could be masked at longer period of times, cannot be ruled out.
The general finding that broiler chicks were not less sensitive than layer chicks in their responsiveness to the satiety signal of the -MSH analog agrees with the findings in rodents. In all genetically and experimentally obese rodent models (except those mutated in MC4R; Marsh et al. 1999), MT-II has been shown to be as effective in attenuating food intake as in control mice (Fan et al. 1997, Hohmann et al. 2000, Pierroz et al. 2002). Moreover, consistent with our finding of a longer period of MT-II effectiveness in broilers, similar results were reported in a model of obesity in rats, in which a longer persistence of the anorectic effect of MT-II treatment was observed in leptin-induced, leptin-resistant rats compared with control lean rats (Scarpace et al. 2003).
The concern about a possible aversive effect of the MT-II treatment is based on a previous publication in rats (Benoit et al. 2003) and 21% of MT-II treated humans (Wessells et al. 2000). However, data accumulated from studies in mammals indicate that the effects of MT-II on food intake and BW are specific. Examples are the report by Seeley et al.(2005) demonstrating that the effects of chronic s.c. infusion of MT-II on food intake are secondary to regulation of body weight and adiposity, and a report by Benoit et al.(2000), where another MC4R agonist (Ro27–3225, clearly non-aversive), imposed similar effects to those of MT-II. For chicken, nothing is known regarding the possibility of aversive effects of MT-II, but taking into account the inspected normal behavior of the treated chicks, the similarity of MT-II effects in the chicks with those following i.c.v. injection to ring dove (Strader et al. 2003) and those reported in mammals, suggests that the MT-II effects on the broiler and layer chicks reported here are specific.
For both rodents and birds, the similarity of the effects obtained by i.c.v. injection and peripheral injection (at much higher amounts when calculated as micrograms per animal), suggests that the main site of action of MT-II is the brain (Murphy et al. 2000, Azzara et al. 2002, Moran et al. 2002, Pierroz et al. 2002, Bellinger et al. 2003, Choi et al. 2003, Hansen et al. 2005), but some contradictory results in rodent suggested that MT-II does not cross the blood–brain barrier (Trivedi et al. 2003). Taking this into account and the wide peripheral tissue specificity of expression of MC3R and MC4R in chickens (Takeuchi & Takahashi 1998, 1999), we cannot exclude the possibility that the injected MT-II operated through peripheral receptors.
Although MT-II is a non-selective agonist of MCRs, its effect on feeding, at least in rodents, is mainly mediated by MC4R. This was clearly demonstrated with MC4R-deficient mice (Huszar et al. 1997). MT-II administration in these mice, applied either i.c.v. or peripherally, had no detectable effect on food intake (Marsh et al. 1999, Chen et al. 2000), while strongly attenuating food intake in the normal control mice. The chicken MC4R, sharing on average, 87% identity with its mammalian homologs, has been cloned (Takeuchi & Takahashi 1998). Initial characterization of MC4R’s expression pattern by RT-PCR showed a similarity in expression in the brain, but a wider range of peripheral expression compared with mammals (Takeuchi & Takahashi 1998).
The high affinity of the synthetic MT-II to chicken MCRs was demonstrated by the use of MCR-transfected cells in culture (Ling et al. 2004). By expressing each of the chicken MCR cDNAs in HEK-293 cells, these authors demonstrated a very high potency of MT-II and human ACTH for the activation of the chicken MC3R and MC4R, whereas -MSH was much less effective in these experiments. Since the human and chicken ACTH sequences differ by only two substitutions, it seems logical to assume that similar results would be obtained also with the chicken-derived ACTH, therefore suggesting that in chickens, ACTH, rather than -MSH, is the primary natural agonist of the MC4R receptor. This hypothesis is also compatible with the fact that in chickens, the intermediate lobe, which is the major source of -MSH in other vertebrates, is not well developed and with the suggestion that -MSH in chickens operates in autocrine and paracrine rather than endocrine circuits (Takeuchi et al. 2003, Boswell & Takeuchi 2005).
In humans, mutations in the MC4R appear to be the most common monogenic cause of obesity known today accounting for about 5% of the morbidly obese population (Farooqi et al. 2000). The similarity between broiler and layer chicks with respect to their response to MT-II injection suggests that the obese phenotype of the broiler strain does not stem from impaired MC4R signaling. Therefore, these receptor agonists are potential future agents for the control of feeding in broiler breeder flocks. The recent finding of an orally active non-peptide antagonist of MC4R (Tucci et al. 2005) suggests the possibility of identifying a suitable agent that could be mixed with food and control feed intake in direct proportion to its consumption.
Expression studies of the POMC gene, encoding the precursor proteins of -MSH, ACTH, and several other peptides in the hypothalamus, showed a high degree of similarity between broilers and layers. A relatively high level of mRNA expression was observed in both strains under conditions of being fed ad libitum, followed by a markedly reduced level after 1 week of feed restriction. Given that a much higher fat content is typical to broiler chicks even at this young age (Griffin et al. 1991), and assuming that adipose-secreted proteins elicit brain response in chickens (Horev et al. 2000, Ohkubo et al. 2000) similarly to that described for mammals (Ahima & Flier 2000, Saltiel 2001), a much higher hypothalamic POMC level would be expected under the assumption of similar sensitivity to these fat-secreted signals. Therefore, despite our results showing the higher fat content of the broiler chicks, the similarity of POMC steady-state levels in their hypothalamus to those of layer chicks suggests a lower sensitivity of broiler chicks to these satiety signals. It is logical to assume that control mechanisms operating upstream of POMC activation in response to satiety signals from peripheral tissues operate at a lower efficiency, possibly contributing to the obese phenotype of broiler breeders.
The stronger down-regulation of POMC mRNA expression observed in the layer hypothalamus correlates with the almost total lack of abdominal fat observed in these animals compared with the significant amount of fat tissue still present in the feed-restricted broilers (not shown). However, a more accurate means of mRNA quantization is required to confirm this observation.
The use of broiler and layer chickens, the two most important commercial strains, as a model system to study the physiological aspects of obesity is of high importance for both academic and agricultural research. In order to study the genetics of these traits, a number of laboratories have established their own selection procedure towards the generation of strains with more defined founder population and traits (such as high and low BW, abdominal fat, plasma very low density lipoprotein concentration, and fasting glycemia; Whitehead & Griffin 1984, Cahaner & Nitsan 1985, Simon & Leclercq 1985, Dunnington & Siegel 1996, Park et al. 2006). A striking phenomenon that appeared from these experimental breeding programs and from the commercial breeding programs is the non-exhausting genetic variation for these traits. This phenomenon, recently coined by Eitan & Soller (2004) as the "Selection Induced Genetic Variation" (SIGV), was especially evident in the long-term divergent selection for BW initiated in 1957 (Dunnington & Siegel 1996, Carlborg et al. 2006) as well as in the long-term commercial selection of broiler chickens. Recent quantitative trait loci analysis has identified four interacting loci comprising of more than 800 F2 bird progeny of reciprocal intercross between the long tern-selected lines with high and low BW (Jacobsson et al. 2005, Park et al. 2006). The authors suggested that interlocus interactions (epistasis) between these loci, along with the increasing proportion of beneficial allelic combinations for the selected trait, led to the release of new genetic variation with multiple synergistic interactions. This comprehensive QTL analysis and the use of an epistatic approach provided the first empirical support for explaining this phenomenon of SIGV, thus offering a classical Mendelian explanation for a seemingly Lamarckistic-type phenomenon.
The study on candidate gene function such as those of MC3/4R agonists described here may contribute to deciphering the high complexity of the control mechanism on energy balance in chickens. The importance of studying agonists of the MC3/4R is due not only to their affect on appetite and BW but also to their potential enhancing effect on the hypothalamus–pituitary–gonadal axis (Kim et al. 2000, Watanobe et al. 2001). Experiments involving prolonged treatments in chickens are therefore needed to assess the possible involvement of the melanocortin-receptor circuit in the regulation of obesity and reproduction.
|
Acknowledgements |
|---|
|
Funding |
|---|
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Al-Obeidi F, Hruby VJ, Castrucci AM & Hadley ME 1989a Design of potent linear alpha-melanotropin 4–10 analogues modified in positions 5 and 10. Journal of Medicinal Chemistry 32 174–179.[CrossRef][ISI][Medline]
Al-Obeidi F, Castrucci AM, Hadley ME & Hruby VJ 1989b Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics. Journal of Medicinal Chemistry 32 2555–2561.[CrossRef][ISI][Medline]
Azzara AV, Sokolnicki JP & Schwartz GJ 2002 Central melanocortin receptor agonist reduces spontaneous and scheduled meal size but does not augment duodenal preload-induced feeding inhibition. Physiology and Behavior 77 411–416.[CrossRef][Medline]
Bellinger L, Cepeda-Benito A, Bullard RL & Wellman PJ 2003 Effect of i.c.v. infusion of the alpha-MSH agonist MTII on meal patterns in male rats following nicotine withdrawal. Life Sciences 73 1861–1872.[CrossRef][ISI][Medline]
Benoit SC, Schwartz MW, Lachey JL, Hagan MM, Rushing PA, Blake KA, Yagaloff KA, Kurylko G, Franco L, Danhoo W et al. 2000 A novel selective melanocortin-4 receptor agonist reduces food intake in rats and mice without producing aversive consequences. Journal of Neuroscience 20 3442–3448.
Benoit SC, Air EL, Coolen LM, Strauss R, Jackman A, Clegg DJ, Seeley RJ & Woods SC 2002 The catabolic action of insulin in the brain is mediated by melanocortins. Journal of Neuroscience 22 9048–9052.
Benoit SC, Sheldon RJ, Air EL, Messerschmidt P, Wilmer KA, Hodge KM, Jones MB, Eckstein DM, McOsker CC, Woods SC et al. 2003 Assessment of the aversive consequences of acute and chronic administration of the melanocortin agonist, MTII. International Journal of Obesity and Related Metabolic Disorders 27 550–556.[CrossRef]
Bokkers EA & Koene P 2003 Eating behaviour, and preprandial and postprandial correlations in male broiler and layer chickens. British Poultry Science 44 538–544.[CrossRef][ISI][Medline]
Boswell T & Takeuchi S 2005 Recent developments in our understanding of the avian melanocortin system: its involvement in the regulation of pigmentation and energy homeostasis. Peptides 26 1733–1743.[CrossRef][ISI][Medline]
Cahaner A & Nitsan Z 1985 Evaluation of simultaneous selection for live body weight and against abdominal fat in broilers. Poultry Science 64 1257–1263.[ISI][Medline]
Carlborg O, Jacobsson L, Ahgren P, Siegel P & Andersson L 2006 Epistasis and the release of genetic variation during long-term selection. Nature Genetics 38 418–420.[CrossRef][ISI][Medline]
Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan XM, Yu H, Rosenblum CI, Vongs A, Feng Y, Cao L et al. 2000 Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nature Genetics 26 97–102.[CrossRef][ISI][Medline]
Choi YH, Li C, Hartzell DL, Lin J, Della-Fera MA & Baile CA 2003 MTII administered peripherally reduces fat without invoking apoptosis in rats. Physiology and Behavior 79 331–337.[CrossRef][Medline]
Dunnington EA & Siegel PB 1996 Long-term divergent selection for eight-week body weight in white Plymouth rock chickens. Poultry Science 75 1168–1179.[ISI][Medline]
Eitan Y & Soller M 2004 In Evolutionary Theory and Processes: Modern Horizons. Papers in Honor of Eviatar Nevo, pp 153–176. Ed SP Wasser. Dordrecht, The Netherlands: Kluwer Academic.
Fan W, Boston BA, Kesterson RA, Hruby VJ & Cone RD 1997 Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385 165–168.[CrossRef][Medline]
Farooqi IS & O’Rahilly S 2005 Monogenic obesity in humans. Annual Review of Medicine 56 443–458.[CrossRef][ISI][Medline]
Farooqi IS, Yeo GS, Keogh JM, Aminian S, Jebb SA, Butler G, Cheetham T & O’Rahilly S 2000 Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. Journal of Clinical Investigation 106 271–279.[ISI][Medline]
Friedman JM 2002 The function of leptin in nutrition, weight, and physiology. Nutrition Reviews 60. S1–14; discussion S68–S84 85–17.[ISI][Medline]
Gerets HH, Peeters K, Arckens L, Vandesande F & Berghman LR 2000 Sequence and distribution of proopiomelanocortin in the pituitary and the brain of the chicken (Gallus gallus). Journal of Comparative Neurology 417 250–262.[CrossRef][ISI][Medline]
Gilbert C, Acamovic T & Bedford MR 1999 Effect of enzyme supplementation on the growth and food conversion efficiency of broiler chicks on lupin-based diets. British Poultry Science 40 (Suppl) S31–S32.[Medline]
Griffin HD, Windsor D & Goddard C 1991 Why are young broiler chickens fatter than layer-strain chicks? Comparative Biochemistry and Physiology A 100 205–210.[CrossRef]
Hansen MJ, Schioth HB & Morris MJ 2005 Feeding responses to a melanocortin agonist and antagonist in obesity induced by a palatable high-fat diet. Brain Research 1039 137–145.[CrossRef][ISI][Medline]
Haskell-Luevano C, Miwa H, Dickinson C, Hruby VJ, Yamada T & Gantz I 1994 Binding and cAMP studies of melanotropin peptides with the cloned human peripheral melanocortin receptor, hMC1R. Biochemical and Biophysical Research Communications 204 1137–1142.[CrossRef][ISI][Medline]
Hocking PM & Robertson GW 2005 Limited effect of intense genetic selection for broiler traits on ovarian function and follicular sensitivity in broiler breeders at the onset of lay. British Poultry Science 46 354–360.[CrossRef][ISI][Medline]
Hocking PM, Hughes BO & Keer-Keer S 1997 Comparison of food intake, rate of consumption, pecking activity and behaviour in layer and broiler breeder males. British Poultry Science 38 237–240.[ISI][Medline]
Hohmann JG, Teal TH, Clifton DK, Davis J, Hruby VJ, Han G & Steiner RA 2000 Differential role of melanocortins in mediating leptin’s central effects on feeding and reproduction. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 278 R50–R59.
Horev G, Einat P, Aharoni T, Eshdat Y & Friedman-Einat M 2000 Molecular cloning and properties of the chicken leptin-receptor (CLEPR) gene. Molecular and Cellular Endocrinology 162 95–106.[CrossRef][ISI][Medline]
Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD et al. 1997 Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88 131–141.[CrossRef][ISI][Medline]
Jacobsson L, Park HB, Wahlberg P, Fredriksson R, Perez-Enciso M, Siegel PB & Andersson L 2005 Many QTLs with minor additive effects are associated with a large difference in growth between two selection lines in chickens. Genetical Research 86 115–125.[CrossRef][ISI][Medline]
Kask A & Schioth HB 2000 Tonic inhibition of food intake during inactive phase is reversed by the injection of the melanocortin receptor antagonist into the paraventricular nucleus of the hypothalamus and central amygdala of the rat. Brain Research 887 460–464.[CrossRef][ISI][Medline]
Kawakami S, Bungo T, Ando R, Ohgushi A, Shimojo M, Masuda Y & Furuse M 2000 Central administration of alpha-melanocyte stimulating hormone inhibits fasting- and neuropeptide Y-induced feeding in neonatal chicks. European Journal of Pharmacology 398 361–364.[CrossRef][ISI][Medline]
Kim MS, Small CJ, Stanley SA, Morgan DG, Seal LJ, Kong WM, Edwards CM, Abusnana S, Sunter D, Ghatei MA et al. 2000 The central melanocortin system affects the hypothalamopituitary thyroid axis and may mediate the effect of leptin. Journal of Clinical Investigation 105 1005–1011.[ISI][Medline]
Kuenzel WJ & Kuenzel NT 1977 Basal metabolic rate in growing chicks Gallus domesticus. Poultry Science 56 619–627.[ISI][Medline]
Leenstra FR & Pit R 1988 Fat deposition in a broiler sire strain. 3. Heritability of and genetic correlations among body weight, abdominal fat, and feed conversion. Poultry Science 67 1–9.[ISI][Medline]
Ling MK, Hotta E, Kilianova Z, Haitina T, Ringholm A, Johansson L, Gallo-Payet N, Takeuchi S & Schioth HB 2004 The melanocortin receptor subtypes in chicken have high preference to ACTH-derived peptides. British Journal of Pharmacology 143 626–637.[CrossRef][ISI][Medline]
MacLeod MG, Bernard K, McNeill L & Knox A 1999 Comparison of food intake, body weight gain and food conversion efficiency on broiler starter diets formulated on metabolisable and net energy. British Poultry Science 40 (Suppl) S38–S39.[Medline]
Marks HL 1980 Growth, feed intake, and feed conversion of dwarf and nondwarf broiler-type chickens. Poultry Science 59 2183–2188.[ISI][Medline]
Marsh DJ, Hollopeter G, Huszar D, Laufer R, Yagaloff KA, Fisher SL, Burn P & Palmiter RD 1999 Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nature Genetics 21 119–122.[CrossRef][ISI][Medline]
Matsumura R, Takagi C, Kakeya T, Okuda K, Takeuchi S & Takahashi S 2003 Alpha-melanocyte stimulating hormone stimulates prolactin secretion through melanocortin-3 receptors expressed in mammotropes in the mouse pituitary. Neuroendocrinology 78 96–104.[CrossRef][ISI][Medline]
Mench JA 2002 Broiler breeders: feed restriction and welfare. Worlds Poultry Science Journal 58 20–29.
Moran TH, Lee P, Ladenheim EE & Schwartz GJ 2002 Responsivity to NPY and melanocortins in obese OLETF rats lacking CCK-A receptors. Physiology and Behavior 75 397–402.[CrossRef][Medline]
Morris TR & Njuru DM 1990 Protein requirement of fast- and slow-growing chicks. British Poultry Science 31 803–810.[ISI][Medline]
Mountjoy KG, Jenny Wu CS, Dumont LM & Wild JM 2003 Melanocortin-4 receptor messenger ribonucleic acid expression in rat cardiorespiratory, musculoskeletal, and integumentary systems. Endocrinology 144 5488–5496.
Murphy B, Nunes CN, Ronan JJ, Hanaway M, Fairhurst AM & Mellin TN 2000 Centrally administered MTII affects feeding, drinking, temperature, and activity in the Sprague-Dawley rat. Journal of Applied Physiology 89 273–282.
Ohkubo T, Tanaka M & Nakashima K 2000 Structure and tissue distribution of chicken leptin receptor (cOb-R) mRNA. Biochimica et Biophysica Acta 1491 303–308.[Medline]
Ohta Y, Yoshida T & Tsushima N 2004 Comparison between broilers and layers for growth and protein use by embryos. Poultry Science 83 783–787.
Ottaviani E, Franchini A & Franceschi C 1997 Evolution of neuroendocrine thymus: studies on POMC derived peptides, cytokines and apoptosis in lower and higher vertebrates. Journal of Neuroimmunology 72 67–74.[CrossRef][ISI][Medline]
Pankov Iu A 2005 [The role of leptin and its peptide mediators in neurophysiology]. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 44–48.
Park HB, Jacobsson L, Wahlberg P, Siegel PB & Andersson L 2006 QTL analysis of body composition and metabolic traits in an intercross between chicken lines divergently selected for growth. Physiological Genomics 216–223.
Pierroz DD, Ziotopoulou M, Ungsunan L, Moschos S, Flier JS & Mantzoros CS 2002 Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity. Diabetes 51 1337–1345.
Saito S, Takagi T, Koutoku T, Saito ES, Hirakawa H, Tomonaga S, Tachibana T, Denbow DM & Furuse M 2004 Differences in catecholamine metabolism and behaviour in neonatal broiler and layer chicks. British Poultry Science 45 158–162.[CrossRef][ISI][Medline]
Saltiel AR 2001 You are what you secrete. Nature Medicine 7 887–888.[CrossRef][ISI][Medline]
Sambrook J & Russell DW 2001 Molecular Cloning: A Laboratory Manual. 3rd ed, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
Sato M, Tachibana T & Furuse M 2006 Heat production and lipid metabolism in broiler and layer chickens during embryonic development. Comparative Biochemistry and Physiology A. Molecular and Integrative Physiology 143 382–388.[CrossRef]
Saunderson CL & Leslie S 1988 Muscle growth and protein degradation during early development in chicks of fast and slow growing strains. Comparative Biochemistry and Physiology 89 333–337.[Medline]
Scarpace PJ, Matheny M, Zolotukhin S, Tumer N & Zhang Y 2003 Leptin-induced leptin resistant rats exhibit enhanced responses to the melanocortin agonist MT II. Neuropharmacology 45 211–219.[CrossRef][ISI][Medline]
Schioth HB, Muceniece R, Mutulis F, Prusis P, Lindeberg G, Sharma SD, Hruby VJ & Wikberg JE 1997 Selectivity of cyclic [D-Nal7] and [D-Phe7] substituted MSH analogues for the melanocortin receptor subtypes. Peptides 18 1009–1013.[CrossRef][ISI][Medline]
Schioth HB, Lagerstrom MC, Watanobe H, Jonsson L, Vergoni AV, Ringholm A, Skarphedinsson JO, Skuladottir GV, Klovins J & Fredriksson R 2003 Functional role, structure, and evolution of the melanocortin-4 receptor. Annals of the New York Academy of Sciences 994 74–83.[CrossRef][ISI][Medline]
Schneider JE, Buckley CA, Blum RM, Zhou D, Szymanski L, Day DE & Bartness TJ 2002 Metabolic signals, hormones and neuropeptides involved in control of energy balance and reproductive success in hamsters. European Journal of Neuroscience 16 377–379.[CrossRef][ISI][Medline]
Schwartz MW, Woods SC, Porte D Jr., Seeley RJ & Baskin DG 2000 Central nervous system control of food intake. Nature 404 661–671.[Medline]
Seeley RJ, Yagaloff KA, Fisher SL, Burn P, Thiele TE, van Dijk G, Baskin DG & Schwartz MW 1997 Melanocortin receptors in leptin effects. Nature 390 349.[Medline]
Seeley RJ, Burklow ML, Wilmer KA, Matthews CC, Reizes O, McOsker CC, Trokhan DP, Gross MC & Sheldon RJ 2005 The effect of the melanocortin agonist, MT-II, on the defended level of body adiposity. Endocrinology 3732–3738.
Simon J & Leclercq B 1985 Fat and lean chickens: prefattening period and in vivo sensitivity to insulin, atropine, and propranolol. American Journal of Physiology 249 R393–R401.[Medline]
Small CJ, Stanley SA & Bloom SR 2002 Appetite control and reproduction: leptin and beyond. Seminars in Reproductive Medicine 20 389–398.[CrossRef][ISI][Medline]
Strader AD, Schioth HB & Buntin JD 2003 The role of the melanocortin system and the melanocortin-4 receptor in ring dove (Streptopelia risoria) feeding behavior. Brain Research 960 112–121.[CrossRef][ISI][Medline]
Tachibana T, Sugahara K, Ohgushi A, Ando R, Sashihara K, Yoshimatsu T & Furuse M 2001 Intracerebroventricular injection of exendin (5–39) increases food intake of layer-type chicks but not broiler chicks. Brain Research 915 234–237.[CrossRef][ISI][Medline]
Tachibana T, Sato M, Oikawa D & Furuse M 2006 Involvement of CRF on the anorexic effect of GLP-1 in layer chicks. Comparative Biochemistry and Physiology A. Molecular and Integrative Physiology 143 112–117.[CrossRef]
Takagi T, Bungo T, Tachibana T, Saito CS, Saito S, Yamasaki I, Tomonaga S, Denbow DM & Furuse M 2003 Intracerebroventricular administration of GABA-A and GABA-B receptor agonists attenuate feeding and sleeping-like behaviour induced by L-pipecolic acid in neonatal chicks. Journal of Neuroscience Research 73 270–275.[CrossRef][ISI][Medline]
Takeuchi S & Takahashi S 1998 Melanocortin receptor genes in the chicken–tissue distributions. General and Comparative Endocrinology 112 220–231.[CrossRef][ISI][Medline]
Takeuchi S & Takahashi S 1999 A possible involvement of melanocortin 3 receptor in the regulation of adrenal gland function in the chicken. Biochimica et Biophysica Acta 1448 512–518.[Medline]
Takeuchi S, Suzuki H, Yabuuchi M & Takahashi S 1996 A possible involvement of melanocortin 1-receptor in regulating feather color pigmentation in the chicken. Biochimica et Biophysica Acta 1308 164–168.[Medline]
Takeuchi S, Kudo T & Takahashi S 1998 Molecular cloning of the chicken melanocortin 2 (ACTH)-receptor gene. Biochimica et Biophysica Acta 1403 102–108.[Medline]
Takeuchi S, Teshigawara K & Takahashi S 1999 Molecular cloning and characterization of the chicken proopiomelanocortin (POMC) gene. Biochimica et Biophysica Acta 1450 452–459.[Medline]
Takeuchi S, Takahashi S, Okimoto R, Schioth HB & Boswell T 2003 Avian melanocortin system: alpha-MSH may act as an autocrine/paracrine hormone: a minireview. Annals of the New York Academy of Sciences 994 366–372.[ISI][Medline]
Tolkamp BJ, Sandilands V & Kyriazakis I 2005 Effects of qualitative feed restriction during rearing on the performance of broiler breeders during rearing and lay. Poultry Science 84 1286–1293.
Trivedi P, Jiang M, Tamvakopoulos CC, Shen X, Yu H, Mock S, Fenyk-Melody J, Van der Ploeg LH & Guan XM 2003 Exploring the site of anorectic action of peripherally administered synthetic melanocortin peptide MT-II in rats. Brain Research 977 221–230.[CrossRef][ISI][Medline]
Tucci FC, White NS, Markison S, Joppa M, Tran JA, Fleck BA, Madan A, Dyck BP, Parker J, Pontillo J et al. 2005 Potent and orally active non-peptide antagonists of the human melanocortin-4 receptor based on a series of trans-2-disubstituted cyclohexylpiperazines. Bioorganic and Medicinal Chemistry 2389–2395.
Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B & Froguel P 2000 Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. Journal of Clinical Investigation 106 253–262.[ISI][Medline]
Watanobe H, Yoneda M, Kakizaki Y, Kohsaka A, Suda T & Schioth HB 2001 Further evidence for a significant participation of the melanocortin 4 receptor in the preovulatory prolactin surge in the rat. Brain Research Bulletin 54 521–525.[CrossRef][ISI][Medline]
Wessells H, Gralnek D, Dorr R, Hruby VJ, Hadley ME & Levine N 2000 Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction. Urology 56 641–646.[CrossRef][ISI][Medline]
Whitehead CC & Griffin HD 1984 Development of divergent lines of lean and fat broilers using plasma very low density lipoprotein concentration as selection criterion: the first three generations. British Poultry Science 25 573–582.[ISI][Medline]
Williams DL, Kaplan JM & Grill HJ 2000 The role of the dorsal vagal complex and the vagus nerve in feeding effects of melanocortin-3/4 receptor stimulation. Endocrinology 141 1332–1337.
Williams G, Bing C, Cai XJ, Harrold JA, King PJ & Liu XH 2001 The hypothalamus and the control of energy homeostasis: different circuits, different purposes. Physiology and Behavior 74 683–701.[CrossRef][Medline]
Yang Y, Dickinson C, Haskell-Luevano C & Gantz I 1997 Molecular basis Haskesis for the interaction of [Nle4,DPhe7] melanocyte stimulating hormone with the human melanocortin-1 receptor. Journal of Biological Chemistry 272 23000–23010.
Received in final form 7 April 2006
Accepted 21 April 2006
Made available online as an Accepted Preprint 10 May 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP |
